Loading...

By Sofía Garduño - Tue, 07/22/2025 - 08:17

J&J submits NDA for icotrokinra, an oral IL-23 blocker for plaque psoriasis, based on four Phase 3 trials showing strong efficacy and safety.

Partnership Content

https://mexicobusiness.news/tag/autoimmune-disease

More Health

By Sofía Garduño - Fri, 05/30/2025 - 11:09

World MS Day highlights the need for early diagnosis and better care to improve outcomes and reduce disability for people living with this condition.

By MBN Staff - Mon, 10/07/2024 - 10:25

Roche's Gazyva demonstrates significant benefits in lupus nephritis, improving kidney function and offering hope for effective treatment options.

By MBN Staff - Tue, 06/11/2024 - 17:06

Ipsen and Genfit receive approval for Iqirvo, a new treatment for chronic liver disease, with potential benefits over existing therapies